Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
216,2 INR | -3,07 % | -6,91 % | +26,61 % |
Resumen de negocios
Número de empleados: 1 295
Ventas por actividad
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Contract Research and Manufacturing Services
80,6
%
| 16 493 | 77,0 % | 19 453 | 80,6 % | +17,95 % |
Marketable Molecules (including Others)
19,4
%
| 4 914 | 23,0 % | 4 676 | 19,4 % | -4,83 % |
Ventas por región
INR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
India
100,0
%
| 367 | 1,7 % | 24 129 | 100,0 % | +6.483,68 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 38 | 07/04/12 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 42 | - |
Paolo Armanino
COO | Chief Operating Officer | - | - |
Compliance Officer | 37 | 17/03/17 | |
Dharmesh Desai
LAW | General Counsel | - | - |
Martin Schneider
PRN | Corporate Officer/Principal | - | - |
Stephan Fritschi
PRN | Corporate Officer/Principal | 63 | - |
Dieter Thueer
HRO | Human Resources Officer | - | - |
Alan Fischer
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 73 | 17/03/07 | |
Director/Board Member | 73 | 17/03/17 | |
Director/Board Member | 76 | 17/03/17 | |
Chief Executive Officer | 38 | 07/04/12 | |
Subir Kumar Das
BRD | Director/Board Member | 70 | 17/03/17 |
Director/Board Member | 42 | 01/04/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 156 783 095 | 46 925 444 ( 29,93 %) | 0 | 29,93 % |
Información de la empresa
Dishman Carbogen Amcis Ltd.
Dishman Corporate House Opp. Jayantilal Park BRTS
380058, Ahmedabad
+91 27 1742 0102
http://imdcal.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The private company is based in London, UK. Dishman Europe was founded in 1997. |
Pharmaceuticals: Major
|
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The private company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. |
Pharmaceuticals: Other
|
Ventas por actividad
Ventas por región
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+31,52 % | 690 mil M | |
+21,96 % | 546 mil M | |
-5,21 % | 358 mil M | |
+17,02 % | 323 mil M | |
+5,01 % | 287 mil M | |
+13,68 % | 235 mil M | |
+3,81 % | 199 mil M | |
-10,63 % | 195 mil M | |
+3,98 % | 161 mil M |
- Bolsa de valores
- Acciones
- Acción DCAL
- Acción DCAL
- Empresa Dishman Carbogen Amcis Limited